1α, 25 — Dihydroxyvitamin D3 modulates the growth of 3T3 cells and human skin fibroblasts stimulated by platelet-derived growth factor

[1]  J. Pike.  Intracellular receptors mediate the biologic action of 1,25-dihydroxyvitamin D3. , 2009, Nutrition reviews.

[2]  L. Vicentini,et al.  Activation of Na+/H+ exchange in cultured fibroblasts: synergism and antagonism between phorbol ester, Ca2+ ionophore, and growth factors. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Holick,et al.  Cultured psoriatic fibroblasts from involved and uninvolved sites have a partial but not absolute resistance to the proliferation-inhibition activity of 1,25-dihydroxyvitamin D3. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Thomasset,et al.  [Molecular approach to the action of vitamin D in man]. , 1985, Archives francaises de pediatrie.

[5]  I. Macara.  Oncogenes, ions, and phospholipids. , 1985, The American journal of physiology.

[6]  M. Waterfield,et al.  Purification and properties of porcine platelet‐derived growth factor. , 1984, The EMBO journal.

[7]  H. DeLuca,et al.  Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues. , 1984, Cancer research.

[8]  M. Fanger,et al.  Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). , 1984, The Journal of clinical investigation.

[9]  H. Antoniades.  Platelet-derived growth factor and malignant transformation. , 1984, Biochemical pharmacology.

[10]  Gary R. Grotendorst,et al.  Cellular transformation by coordinated action of three peptide growth factors from human platelets , 1984, Nature.

[11]  D. Ducassou,et al.  In vitro stimulation of articular chondrocyte differentiated function by 1,25‐dihydroxycholecalciferol or 24R,25‐dihydroxycholecalciferol , 1984, Journal of cellular physiology.

[12]  J. Goldman,et al.  A ROLE FOR 1,25-DIHYDROXYVITAMIN D3 IN CONTROL OF BONE-MARROW COLLAGEN DEPOSITION? , 1984, The Lancet.

[13]  D. Catovsky,et al.  The effect of vitamin D3 metabolites on normal and leukemic bone marrow cells in vitro. , 1984, International journal of cell cloning.

[14]  B. Gilchrest,et al.  Interaction of 1,25-dihydroxyvitamin-D3 with keratinocytes and fibroblasts from skin of normal subjects and a subject with vitamin-D-dependent rickets, type II: a model for study of the mode of action of 1,25-dihydroxyvitamin D3. , 1983, The Journal of clinical endocrinology and metabolism.

[15]  S. Marx,et al.  Nuclear uptake of 1,25-dihydroxy[3H]cholecalciferol in dispersed fibroblasts cultured from normal human skin. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[16]  W. Vainchenker,et al.  Defective alpha-granule production in megakaryocytes from gray platelet syndrome: ultrastructural studies of bone marrow cells and megakaryocytes growing in culture from blood precursors. , 1981, The American journal of pathology.

[17]  A. Norman,et al.  Biochemical properties of 1α,25-dihydroxyvitamin D receptors , 1980 .

[18]  J. Groopman,et al.  The pathogenesis of myelofibrosis in myeloproliferative disorders. , 1980, Annals of internal medicine.